quetiapine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases withdrawal due to adverse events
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“While dropouts due to inefficacy were significantly lower in the quetiapine group (RR 0.31, 95% CI 0.19 to 0.53), dropouts due to adverse events were significantly higher in the quetiapine group (RR 1.88, 95% CI 1.20 to 2.96).”
Quoted verbatim from Quetiapine for acute bipolar depression: a systematic review and meta-analysis.. - Study
- meta-analysis
- Dose
- 150-600 mg/day
- Population
- Adults and children/adolescents with acute bipolar I or II depression; pooled 11 short-term RCTs of quetiapine versus placebo
Effect 1.88 risk ratio, 95% CI 1.2 to 2.96
Quetiapine for acute bipolar depression: a systematic review and meta-analysis.2014PMID:25028535Permalink
Keep reading
- Everything the graph holds on quetiapine
- Every compound studied against Withdrawal due to adverse events
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45ADCBXKX3YEJP9TFYZRN6W